150 results match your criteria: "Intermountain Primary Children's Hospital[Affiliation]"
J Pediatr
December 2020
Pediatric Gastroenterology, Hepatology and Nutrition, University of Colorado School of Medicine, Children's Hospital Colorado, Aurora, CO.
Objectives: To identify predictors of portal hypertension, liver transplantation, and death in North American youth with alpha-1-antitrypsin (AAT) deficiency, and compare with patients with AAT deficiency elsewhere.
Study Design: The Childhood Liver Disease Research Network Longitudinal Observational Study of Genetic Causes of Intrahepatic Cholestasis is a prospective, cohort study of pediatric cholestatic liver diseases, including AAT deficiency, enrolling PIZZ and PISZ subjects 0-25 years of age seen since November 2007 at 17 tertiary care centers in the US and Canada. Data from standard-of-care baseline and annual follow-up visits were recorded from medical records, history, physical examination, and laboratory studies.
Inflamm Bowel Dis
February 2021
University of North Carolina in Chapel Hill, Chapel Hill, NC, United States.
Background: The incidence of very early onset inflammatory bowel disease (VEOIBD) is increasing, yet the phenotype and natural history of VEOIBD are not well described.
Methods: We performed a retrospective cohort study of patients diagnosed with VEOIBD (6 years of age and younger) between 2008 and 2013 at 25 North American centers. Eligible patients at each center were randomly selected for chart review.
Clin Gastroenterol Hepatol
May 2021
Department of Pediatrics, University of Utah and Intermountain Primary Children's Hospital, Salt Lake City, Utah.
Inflammatory bowel disease (IBD), especially when associated with primary sclerosing cholangitis (PSC), is a risk factor for developing colorectal cancer (CRC). We aimed to determine the incidence of CRC in a large cohort of pediatric-onset PSC-ulcerative colitis (UC) patients.
View Article and Find Full Text PDFPediatr Pulmonol
January 2020
Department of Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah.
Acute pulmonary exacerbations (APE) are a complication of cystic fibrosis (CF) and are associated with morbidity and mortality. Methicillin-resistant Staphylococcus aureus (MRSA) is one of many organisms that has been detected in the airways of patients with CF. This review provides an evidence-based summary of pharmacokinetic/pharmacodynamic (PK/PD), tolerability, and efficacy studies utilizing anti-MRSA antibiotics (ie, ceftaroline, clindamycin, fluoroquinolone derivatives (ciprofloxacin, levofloxacin), glycopeptide derivatives (telavancin, vancomycin), linezolid, rifampin, sulfamethoxazole/trimethoprim (SMZ/TMP), and tetracycline derivatives (doxycycline, minocycline, tigecycline) in the treatment of APE and identifies areas where further study is warranted.
View Article and Find Full Text PDFInt J Surg Case Rep
June 2019
Pediatric Liver Transplantation, Intermountain Primary Children's Hospital, Salt Lake City, UT, USA. Electronic address:
Introduction: In children with extrahepatic portal vein obstruction or those who develop portal vein thrombosis after liver transplant, the use of Meso-Rex Bypass (MRB) creates a more physiological state by redirecting mesenteric blood flow back into the intrahepatic portal system via a venous conduit.
Presentation Of Case: A 3-year-old female with biliary atresia associated with polysplenia syndrome and a surgical history of Kasai portoenterostomy procedure, and an ABO incompatible whole liver transplant. Within a year after transplant she presented with prehepatic portal hypertension, that was treated with MRB using a deceased donor ABO compatible iliac vein as conduit.
Hepatology
September 2019
Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA.
Biliary atresia (BA) is the most common cause of end-stage liver disease in children and the primary indication for pediatric liver transplantation, yet underlying etiologies remain unknown. Approximately 10% of infants affected by BA exhibit various laterality defects (heterotaxy) including splenic abnormalities and complex cardiac malformations-a distinctive subgroup commonly referred to as the biliary atresia splenic malformation (BASM) syndrome. We hypothesized that genetic factors linking laterality features with the etiopathogenesis of BA in BASM patients could be identified through whole-exome sequencing (WES) of an affected cohort.
View Article and Find Full Text PDFInfect Control Hosp Epidemiol
January 2019
1Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School,Boston,Massachusetts.
Objective: To assess variability in antimicrobial use and associations with infection testing in pediatric ventilator-associated events (VAEs).
Design: Descriptive retrospective cohort with nested case-control study.
Setting: Pediatric intensive care units (PICUs), cardiac intensive care units (CICUs), and neonatal intensive care units (NICUs) in 6 US hospitals.
J Clin Pharmacol
February 2019
University of Utah College of Pharmacy, Salt Lake City, UT, USA.
The prevalence of pulmonary methicillin-resistant Staphylococcus aureus infections in patients with cystic fibrosis (CF) has increased over the last 2 decades. Two concentrations-a postdistributive and a trough-are currently used to estimate the area under the curve (AUC) of vancomycin, an antibiotic routinely used to treat these infections, to achieve the target AUC/minimum inhibitory concentration of ≥400 mg·h/L in ensuring optimal dosing of this drug. This study evaluated precision and bias in estimating vancomycin AUCs obtained either from a population pharmacokinetic (PK) model by using a single trough concentration or from standard PK equation-based 2-point monitoring approach.
View Article and Find Full Text PDFMent Health Clin
March 2017
Clinical Pharmacy Specialist, Medical University of South Carolina, Charleston, South Carolina.
Introduction: Written medicine information (WMI) is a collection of facts for a specific medication, and it helps facilitate patient understanding of medication therapy. The primary objective of this study was to assess consumer satisfaction with National Alliance on Mental Illness (NAMI) WMI. A secondary objective was to assess health care professional satisfaction.
View Article and Find Full Text PDFJ Pediatr Pharmacol Ther
January 2017
Riley Hospital for Children at Indiana University Health (RSP), Indianapolis, Indiana, Sanford Medical Center (SJP), Sioux Falls, South Dakota, Texas Children's Hospital (EJM), Houston, Texas, Butler University (KK, RP), Indianapolis, Indiana, St. Vincent's Hospital Riverside (KE), Jacksonville, Florida, University of Wisconsin Hospital (FK), Madison, Wisconsin, Children's Healthcare of Atlanta (MAD), Atlanta, Georgia, and Intermountain Primary Children's Hospital (JTZ), Salt Lake City, Utah.
Objectives: Vancomycin is commonly used in patients with cystic fibrosis (CF) to treat acute pulmonary exacerbations, but few guidelines exist to help dose and monitor patients. The objective of this study was to assess vancomycin use and monitoring strategies at Cystic Fibrosis Foundation (CFF)-accredited centers in hopes of developing and implementing vancomycin dosing and monitoring standards.
Methods: An anonymous national cross-sectional survey of pharmacists affiliated with CFF-accredited pediatric and/or adult centers was performed by using Surveymonkey.
Pediatr Crit Care Med
December 2017
Division of Critical Care, Department of Pediatrics, Intermountain Primary Children's Hospital, University of Utah School of Medicine, Salt Lake City, UT.
Clin Cancer Res
November 2017
Children's Hospital of Philadelphia, and the University of Pennsylvania, Philadelphia, Pennsylvania.
At least 10% of children with cancer harbor a disease-associated pathogenic variant in a known cancer predisposition gene. It is widely accepted that pathogenic variants affecting other genes, epigenetic factors, or abnormalities in additional gene products may contribute to the etiology of many more childhood cancers. Effective preventive measures exist for only a few cancer types associated with predisposing conditions, but the development and implementation of surveillance protocols aimed at reducing morbidity and mortality in at-risk children through the early detection of cancer has emerged as an important clinical tool.
View Article and Find Full Text PDFPediatr Crit Care Med
November 2017
1Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA. 2Division of Critical Care Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA. 3Division of Infectious Diseases, Department of Medicine, Boston Children's Hospital, Boston, MA. 4Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, MA. 5Section of Neonatology, Children's Hospital at Dartmouth, Lebanon, NH. 6Department of Pediatrics, Rainbow Babies and Children's Hospital, Cleveland, OH. 7Division of Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City, UT. 8Department of Patient Safety, Intermountain Primary Children's Hospital, Salt Lake City, UT. 9Section of Infectious Diseases, Department of Pediatrics, Rush University Medical Center, Rush Medical College, Chicago, IL. 10Division of Infectious Diseases, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 11Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Objectives: A newly proposed surveillance definition for ventilator-associated conditions among neonatal and pediatric patients has been associated with increased morbidity and mortality among ventilated patients in cardiac ICU, neonatal ICU, and PICU. This study aimed to identify potential risk factors associated with pediatric ventilator-associated conditions.
Design: Retrospective cohort.
Pediatr Pulmonol
August 2017
Intermountain Cystic Fibrosis Pediatric Center, Salt Lake City, Utah.
Objectives: The purpose of this study is to characterize the impact of pharmacy services on medication adherence and hospitalizations for pediatric cystic fibrosis (CF) patients.
Methods: A retrospective health insurance claims analysis and patient medical charts review from January 1, 2014 to December 31, 2016 of patients from the Pediatric Intermountain CF Center was performed. Adherence to dornase alfa and hospital admissions for pulmonary exacerbations pre and post the implementation of an integrated pharmacy team were reviewed.
Pediatr Pulmonol
July 2017
University of Utah College of Pharmacy, Salt Lake City, Utah.
Clin Cancer Res
June 2017
The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
The prevalence of childhood cancer attributable to genetic predisposition was generally considered very low. However, recent reports suggest that at least 10% of pediatric cancer patients harbor a germline mutation in a cancer predisposition gene. Although some of these children will have a family history suggestive of a cancer predisposition syndrome, many others will not.
View Article and Find Full Text PDFJ Am Pharm Assoc (2003)
February 2019
Community Pharmacy Operations Director, Intermountain Healthcare Pharmacy Services, Salt Lake City, UT.
J Pediatr Pharmacol Ther
July 2016
Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana.
Objectives: Survey suggests that recommended doses and dosage regimens for antipseudomonal antibiotics for the treatment of acute pulmonary exacerbations in cystic fibrosis (CF) patients are not used, and one way to address these disparities is the involvement of pharmacists who are dedicated to CF. This is the first survey specifically designed for pharmacists at Cystic Fibrosis Foundation (CFF)-accredited centers to identify how tobramycin and antipseudomonal beta-lactams are being used. The purpose of this survey is to quantify this information and to promote future study to allow for implementation of tobramycin and beta-lactam dosage and monitoring standardization.
View Article and Find Full Text PDFJ Clin Microbiol
March 2016
University of Utah Department of Pediatrics, Division of Pediatric Infectious Diseases, Salt Lake City, Utah, USA
We evaluated a multiplexed PCR panel for the detection of 16 bacterial, viral, and fungal pathogens in cerebrospinal fluid. Panel results were compared to routine testing, and discrepancies were resolved by additional nucleic acid amplification tests or sequencing. Overall, the positive and negative agreements across methods were 92.
View Article and Find Full Text PDFPediatr Pulmonol
July 2016
Department of Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah.
Am J Health Syst Pharm
March 2015
Lisa W. Goldstone, M.S., Pharm.D., is Assistant Professor, Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson. Shannon N. Saldaña, Pharm.D., M.S., is Pharmacy Clinical Specialist, Psychiatry, Intermountain Primary Children's Hospital, Salt Lake City, UT, and Adjunct Assistant Professor of Psychiatry, School of Medicine, University of Utah, Salt Lake City. Amy Werremeyer, Pharm.D., is Vice Chair and Associate Professor, Department of Pharmacy Practice, College of Pharmacy, Nursing and Allied Sciences, North Dakota State University, Fargo.
Pediatr Pulmonol
June 2015
Departments of Medicine and Pediatrics, Case Western Reserve University School of Medicine, University Hospitals Case Medical Center and Rainbow Babies and Children's Hospital, Cleveland, Ohio.
Objectives: The purpose of this study was to characterize the utilization of antibiotics for chronic methicillin-resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis (CF) patients with acute pulmonary exacerbations (PEx).
Methods: An anonymous national cross-sectional survey of CF Foundation accredited care programs was performed using an electronic survey tool.
Results: Fifty-eight percent (152/261) CF Foundation accredited programs completed the survey.
J Burn Care Res
April 2016
From the *Department of Pediatrics, Division of Clinical Pharmacology, University of Utah, Salt Lake City; †James L. Winkle College of Pharmacy, University of Cincinnati, Ohio; ‡The Shriners Hospitals for Children®, Cincinnati, Ohio; §Intermountain Primary Children's Hospital, Salt Lake City, Utah; and ‖Department of Surgery, University of Cincinnati College of Medicine, Ohio.
This study aimed to develop optimal amikacin dosing regimens for the empirical treatment of Gram-negative bacterial sepsis in pediatric patients with burn injuries. A pharmacodynamic (PD) target in which the peak concentration (Cmax) is ≥8 times the minimum inhibitory concentration (MIC) (Cmax/MIC ≥ 8) is reflective of optimal bactericidal activity and has been used to predict clinical outcomes. Population pharmacokinetic modeling was performed in NONMEM 7.
View Article and Find Full Text PDFPharmacotherapy
August 2014
Department of Pharmacy, Intermountain Primary Children's Hospital, Salt Lake City, Utah; Division of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Study Objective: Antipsychotic polypharmacy-the use of more than one antipsychotic concomitantly-has increased in children and adolescents and may be associated with increased adverse effects, nonadherence, and greater costs. Thus, we sought to examine the demographic and clinical characteristics of psychiatrically hospitalized children and adolescents who were prescribed antipsychotic polypharmacy and to identify predictors of this prescribing pattern.
Design: Retrospective medical record review.